Data from Phase 2 trials (NEJM, 2023) indicate that these effects are generally mild to moderate and transient
They're a special category of compounders that was created by the FDA in the 2013 Drug Quality and Security Act as kind of a stopgap for the drug supply chain, because they can fill in during those times of shortages and try to shore up supply, says Davis
If your vial has been left out of the fridge for extended periods, the medication inside may have partially degraded even though it looks normal
MeAgain vs MacroFactor for GLP-1 food tracking MacroFactor is one of the strongest macro trackers and diet-coaching apps
You will have your weight and body measurements taken on the 3D Styku body composition scanner
The SYNERGY-NASH trial, published in the New England Journal of Medicine in June 2024, provides the strongest evidence we have for tirzepatide (the drug in Mounjaro) in fatty liver disease